伴COPD稳定期术后患者入ICU的风险评估

来源 :中华危重病急救医学 | 被引量 : 0次 | 上传用户:yangying_han
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨伴慢性阻塞性肺疾病(COPD)稳定期术后患者入重症监护病房(ICU)的风险。方法:选择2014年3月至2020年12月中国医科大学附属盛京医院收治的拟行外科手术的COPD稳定期患者。基于慢性阻塞性肺疾病全球倡议(GOLD)指南标准,按照术前气流受限程度分为1级〔第1秒用力呼气容积占预计值百分比(FEV1%)≥80%〕、2级(50%≤FEV1%<80%)、3级(30%≤FEV1%<50%)、4级(FEV1%<30%);基于2021年修订版COPD诊治指南,结合患者症状水平和1年内中、重度急性加重史分为A、B、C、D 4组,其中A组症状最轻、急性加重频率最低且程度最轻,D组症状最重、急性加重最频繁且程度最重。收集患者的一般资料、COPD相关因素、手术相关因素以及术后入ICU的情况,分析术前不同程度气流受限及不同症状综合评估与术后入ICU风险的关系;采用多因素Logistic回归模型分析影响术后入ICU的危险因素。结果:共143例患者纳入分析,根据气流受限程度,GOLD 1级34例、2级72例、3级32例、4级5例;根据症状综合评估,A组78例、B组31例、C组5例、D组29例。不同程度气流受限各组及不同症状综合评估各组间患者的性别、年龄、身高、体质量等一般资料比较差异均无统计学意义。单因素分析显示,术前气流受限程度和症状综合评估与术后入ICU并不相关〔气流受限程度:优势比(n OR)=1.526,95%可信区间(95%n CI)为0.682~3.415,n P=0.304;症状综合评估:n OR=1.508,95%n CI为0.921~2.469,n P=0.103〕。不同程度气流受限各组及不同症状综合评估各组间患者手术部位、手术方式、麻醉方式和手术时间等手术相关因素比较差异均无统计学意义。143例患者中,10例术后入ICU,133例未入ICU。入ICU组患者比未入ICU组年龄更大(岁:73.10±10.56比65.14±9.79,n P<0.05),呼吸困难指数分级更高〔mMRC分级(级):1.5(1.0,2.0)比1.0(0,2.0),n P<0.05〕,每年急性加重频率更高〔次:1(1,2)比0(0,1),n P<0.05〕,且两组患者手术方式差异也有统计学意义。多因素Logistic回归分析结果显示,年龄以及每年急性加重频率是术后入ICU的独立危险因素(年龄:n OR=1.093,95%n CI为1.010~1.183,n P=0.028;每年急性加重频率:n OR=2.400,95%n CI为1.015~5.676,n P=0.046)。n 结论:伴COPD稳定期患者术前气流受限程度和症状综合评估与术后入ICU风险无关;年龄及每年急性加重频率为伴COPD稳定期术后患者入ICU的危险因素。“,”Objective:To observe the risk factors of intensive care unit (ICU) admission for postoperative patients with stable chronic obstructive pulmonary disease (COPD).Methods:Patients with stable COPD who were admitted to Shengjing Hospital of China Medical University for proposed surgical procedures from March 2014 to December 2020 were enrolled. Based on the criteria of the global initiative for chronic obstructive lung disease (GOLD), the patients were classified according to the severity of airflow limitation as grade 1 [forced expiratory volume in one second as a percentage of expected value (FEV1%) ≥ 80%], grade 2 (50% ≤ FEV1% < 80%), grade 3 (30% ≤ FEV1% < 50%), and grade 4 (FEV1% < 30%). Then the patients were divided into groups A, B, C, D according to symptom level and history of moderate/severe acute exacerbation within 1 year. The patients in the group A had the lightest symptoms, the lowest frequency and degree of acute exacerbation, while those in the group D had the most severe symptoms, the most frequent and degree of acute exacerbation. Data of general information, COPD-related factors, surgical-related factors and postoperative admission to ICU were collected. The correlation between different degree of airflow limitation subgroups as well as different comprehensive assessment of symptom subgroups and risk of postoperative ICU admission was analyzed. Multivariate Logistic regression models were used to analyze the risk factors affecting postoperative ICU admission.Results:A total of 143 patients were enrolled in the analysis. According to the degree of airflow limitation, there were 34 patients in GOLD grade 1, 72 in grade 2, 32 in grade 3 and 5 in grade 4. According to the comprehensive assessment of symptoms, there were 78 patients in group A, 31 in group B, 5 in group C and 29 in group D. There were no statistically significant differences in the general data of gender, age, height and weight of patients in each group with different degrees of airflow limitation and different comprehensive assessment of symptoms. Univariate analysis showed that the degree of airflow limitation and comprehensive assessment of symptoms were not associated with postoperative ICU admission [degree of airflow limitation: odds ratio (n OR) = 1.526, 95% confidence interval (95%n CI) was 0.682-3.415, n P = 0.304; comprehensive assessment of symptoms: n OR = 1.508, 95%n CI was 0.921-2.469, n P = 0.103]. There was also no statistically significant difference in the surgical-related factors such as surgical site, surgical method, anesthesia, and surgical duration among the patients with different degrees of airflow limitation and different comprehensive assessment of symptoms. Among the 143 patients, 10 were admitted to ICU postoperation and 133 were not. Compared with the non-admitted ICU patients, patients admitted ICU were older (years old: 73.10±10.56 vs. 65.14±9.79, n P < 0.05), had a higher modified Medical Research Council (mMRC) classification [1.5 (1.0, 2.0) vs. 1.0 (0, 2.0), n P < 0.05], and had more frequent acute exacerbations per year [times: 1 (1, 2) vs. 1 (0, 1), n P < 0.05]. There was also significant difference in surgical method between the two. Multivariate Logistic regression analysis showed that age and frequency of acute exacerbations per year were risk factors for postoperative admission to the ICU (age: n OR = 1.093, 95%n CI was 1.010-1.183, n P = 0.028; frequency of acute exacerbations per year: n OR = 2.400, 95%n CI was 1.015-5.676, n P = 0.046).n Conclusions:Different levels of airflow restriction and symptom comprehensive assessment groupings in stable COPD patients are not associated with the risk of postoperative ICU admission. Age and frequency of acute exacerbations per year were risk factors for postoperative ICU admission.
其他文献
期刊
流感病毒是引起急性呼吸道传染病的常见病原体之一,感染人体后容易导致急性呼吸窘迫综合征(ARDS),是造成流感患者死亡的重要原因。流感病毒通过侵入人体的肺上皮细胞,引起机体广泛的炎症反应及免疫反应,造成组织损伤及细胞凋亡,从而诱导ARDS的发生发展。此外,流感病毒还可以引起机体强烈的氧化应激反应,产生大量活性氧,破坏肺上皮-内皮屏障,造成肺水肿。目前,多项研究已经表明,抗氧化剂对流感病毒感染具有抑制及治疗作用。因此,本文针对流感相关ARDS的流行病学、相关机制、氧化应激反应在流感相关ARDS发生发展中的作用
期刊
期刊
急性呼吸窘迫综合征(ARDS)在临床具有发病率高、病死率高的特点,是导致重症患者死亡的重要因素之一。探索ARDS早期预警、严重程度及预后评估的生物学标志物(组)是研究的重点和难点。代谢紊乱与代谢支持在危重症救治中被日益重视,越来越多的研究表明维生素及其代谢产物变化可动态反映ARDS的损伤环节,并将为ARDS早期诊断、动态评估,乃至特异性治疗靶点筛选提供新的切入点。维生素代谢组学作为代谢组学的重要分支,有助于更好地寻找ARDS的潜在生物标志物。代谢组学是精准医学的最新技术手段,运用代谢组学方法分析维生素代谢
心肺复苏(CPR)指南强调:在抢救心搏骤停患者实施CPR时,应尽早启动胸外心脏按压;同时强调用力按压,快速按压,使胸廓充分回弹,尽量减少按压中断时间。现有机械复苏装置存在按压位置容易偏移、价格昂贵、不易搬动及活塞易脱位等问题;而徒手CPR因高强度的体力损耗,会导致胸外按压深度和频率随着CPR时间延长而下降,从而造成CPR失败;此外,非专业医护人员进行CPR时,大多存在按压位置有偏差、按压深度不准确、胸壁回弹不理想等问题。基于以上因素,解放军总医院第八医学中心重症医学科的医护人员以国际CPR指南为标准,根据
急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)是以顽固性低氧血症为特征、严重威胁患者生命的肺部疾病。代谢组学是对生物或细胞内小分子质量代谢物进行定性和定量分析的一门新兴学科,在疾病发生及诊断中的作用受到越来越多的重视。近年来,许多基于代谢组学筛选出的代谢产物被提出可作为潜在的生物标志物,用于评估ALI/ARDS的早期发展及预后,并为新的靶向干预措施提供依据。本文基于代谢组学探讨内源性代谢物在ALI/ARDS发病机制及生物标志物中的作用,并对其在药物治疗中的应用进行综述。“,”Acute lung in
期刊
期刊
目的:通过对河北省石家庄市治疗新型冠状病毒肺炎(新冠肺炎)的中药处方进行数据分析,以期进一步指导临床运用中医药防治新冠肺炎。方法:将河北省中医院重症医疗队2021年1月7日至3月4日在河北省新冠肺炎定点救治医院河北省胸科医院重症监护病房(ICU)救治的确诊为新冠肺炎的48例出院患者为研究对象。收集患者的性别、年龄、临床分型、既往史以及住院期间首诊和复诊的全部中药处方。基于古今医案云平台(V2.2.1)建立数据库,用频次统计、关联分析、聚类分析、复杂网络分析等方法,对中药处方进行分析。结果:48例确诊新冠肺